Explore Products
Transfected Stable Cell Lines

Human FGFR3 (TACC3_Y373C) BAF3 Cell Line

  • BSL

    1

  • 15
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-X0006C

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Transfected Stable Cell Lines
Size/Quantity

1 vial

Cell Type

Lymphocyte

Shipping Info

Dry Ice

Growth Conditions

37 °C, 5% CO₂

Source Organ

Lymphatic

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Overexpression Stable Cell Lines

Host Cell

BAF3

Description

Human FGFR3 (TACC3_Y373C) BAF3 Cell Line is a genetically engineered model derived from selected murine Ba/F3 parental cell line based on customers’ requirement. FGFR3 (TACC3_Y373C) BAF3 mutant cell line is generated by stable integration of exogenous human FGFR3 gene harboring the TACC3_Y373C composite mutation/fusion into Ba/F3 host cells using our optimized transduction of lentiviral vectors.
Target
The FGFR3-TACC3 fusion involves the fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coil containing protein 3 (TACC3), often coupled with point mutations such as Y373C that enhance oncogenicity. The fusion promotes constitutive FGFR3 kinase activity, disrupted mitotic spindle regulation, and activation of MAPK/ERK and PI3K/AKT pathways. This composite alteration has been observed in glioblastoma, bladder cancer, and lung cancer, and represents a potential therapeutic target. AcceGen offers generation of stable overexpression or fusion gene cell lines targeting any gene or variant of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.

View Product Image

Application

  • For research use only

  • The FGFR3 (TACC3_Y373C) BAF3 Cell Line serves as a powerful tool to investigate FGFR3 fusion- and mutation-driven oncogenic mechanisms and therapeutic interventions. This model enables studies of kinase activation, chromosomal instability, and drug response in hematopoietic systems. It is utilized for high-throughput screening of FGFR inhibitors and evaluation of synthetic lethality and combination therapies.

Inquiring Human FGFR3 (TACC3_Y373C) BAF3 Cell Line

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button